AI & Emerging Technology

Lantheus sells its legacy SPECT business to fusion-tech firm SHINE, sharpening its focus on high-growth PET diagnostics and next-gen cancer therapies.

BridgeBio Pharma hosts a key investor webinar on its oral drug infigratinib for achondroplasia, setting the stage for crucial trial results in Q1 2026.

Neovii Pharmaceuticals names Frédéric Prince its next CEO, bringing deep oncology and gene therapy experience from Roche to steer its next growth phase.

The revered former U.S. Senator announced his withdrawal from public life following a dementia diagnosis, ending a storied career and sparking reflection.

Emmaus Life Sciences outsources its sickle cell drug Endari® in North America to focus on global growth, as NeoImmuneTech gains a key U.S. market foothold.

As CooperCompanies heads to the J.P. Morgan conference, all eyes are on CEO Al White's strategic vision for its dual vision and women's health units.

Apparel brand ATLAS 1 reopens with a collection focused on durability, not novelty, reflecting a major shift in urban fashion toward practical innovation.

A father's life was saved by a quick-thinking guard and a connected AED. His story reveals a blueprint for how communities can fight sudden cardiac arrest.

Ultragenyx's stock plummets after its Osteogenesis Imperfecta drug fails to reduce fractures, a major blow for patients and a test of the firm's pipeline.

A Chinese manufacturer is solving a global branding puzzle, merging bespoke craftsmanship with industrial scale through a unique 'MaaS' production model.

Establishment Labs has submitted its innovative Motiva implants for FDA approval in reconstruction, promising a new era for post-mastectomy care.

Once a cannabis fund, WEDG has completed its rebrand to Nuclear Diamond Batteries, Inc., betting its future on a patented, decades-long power source.

Varsity Spirit and Scripps Sports are launching a pro cheerleading league on national TV. See how paid athletes and a new format will redefine the sport.

The latest VyOS release adds TLS for syslog, AWS GWLB support, and RPKI controls, boosting security and flexibility for modern network infrastructures.

One Times Square now offers limited-time tickets for an up-close look at the famous New Year's Eve Ball before the building's grand 2026 reopening.

Facing a critical cash shortfall, Cue Biopharma turns to the market, betting its promising cancer and autoimmune pipeline can win over investors.

The digital signage firm's new virtual environment lets users explore a full installation, from emergency alerts to video walls, on any device.

Picard Medical rings the NYSE bell, but its stock's volatile journey reflects the high-stakes gamble on its next-generation artificial heart technology.

Leveraging a fleet of vintage F-104 jets, Starfighters Space raises $40M and goes public, aiming to disrupt the small satellite launch market.

Hainan launches unprecedented island-wide customs operations, aiming to become a global trade hub. But can it balance openness with control and rival giants?